EdgarLookup

HANOVER INSURANCE GROUP, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that HANOVER INSURANCE GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
10%
Profit Margin
Net income ÷ revenue
3.9%
Return on Assets
Net income ÷ assets
3.74x
Debt-to-Equity
Total liabilities ÷ equity
+5.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.59B Feb 20, 2026
FY2025 Dec 31, 2024 $6.24B Feb 20, 2026
FY2025 Dec 31, 2023 $5.99B Feb 20, 2026
FY2024 Dec 31, 2022 $5.47B Feb 24, 2025
FY2023 Dec 31, 2021 $5.23B Feb 22, 2024
FY2020 Dec 31, 2020 $1.30B Feb 24, 2021
FY2020 Sep 30, 2020 $1.25B Feb 24, 2021
FY2020 Jun 30, 2020 $1.22B Feb 24, 2021
FY2020 Mar 31, 2020 $1.06B Feb 24, 2021
FY2020 Dec 31, 2019 $1.26B Feb 24, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $662.50M Feb 20, 2026
FY2025 Dec 31, 2024 $426.00M Feb 20, 2026
FY2025 Dec 31, 2023 $35.30M Feb 20, 2026
FY2024 Dec 31, 2022 $116.00M Feb 24, 2025
FY2023 Dec 31, 2021 $422.80M Feb 22, 2024
FY2020 Dec 31, 2020 $164.60M Feb 24, 2021
FY2020 Sep 30, 2020 $118.90M Feb 24, 2021
FY2020 Jun 30, 2020 $115.20M Feb 24, 2021
FY2020 Mar 31, 2020 ($40.00M) Feb 24, 2021
FY2020 Dec 31, 2019 $109.80M Feb 24, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $933.00M Feb 20, 2026
FY2025 Dec 31, 2024 $650.10M Feb 20, 2026
FY2025 Dec 31, 2023 $105.60M Feb 20, 2026
FY2024 Dec 31, 2022 $285.10M Feb 24, 2025
FY2023 Dec 31, 2021 $432.30M Feb 22, 2024
FY2022 Dec 31, 2020 $484.70M Feb 23, 2023
FY2021 Dec 31, 2019 $453.60M Feb 25, 2022
FY2020 Dec 31, 2018 $406.50M Feb 24, 2021
FY2019 Dec 31, 2017 $327.30M Feb 24, 2020
FY2018 Dec 31, 2016 $192.90M Feb 22, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.18B Feb 20, 2026
FY2025 Dec 31, 2024 $806.40M Feb 20, 2026
FY2025 Dec 31, 2023 $361.70M Feb 20, 2026
FY2024 Dec 31, 2022 $722.30M Feb 24, 2025
FY2023 Dec 31, 2021 $823.70M Feb 22, 2024
FY2022 Dec 31, 2020 $707.60M Feb 23, 2023
FY2021 Dec 31, 2019 $602.90M Feb 25, 2022
FY2020 Dec 31, 2018 $551.30M Feb 24, 2021
FY2019 Dec 31, 2017 $704.60M Feb 24, 2020
FY2018 Dec 31, 2016 $743.40M Feb 22, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.70M Feb 20, 2026
FY2025 Dec 31, 2024 $10.20M Feb 20, 2026
FY2025 Dec 31, 2023 $11.90M Feb 20, 2026
FY2024 Dec 31, 2022 $17.80M Feb 24, 2025
FY2023 Dec 31, 2021 $8.00M Feb 22, 2024
FY2022 Dec 31, 2020 $14.90M Feb 23, 2023
FY2021 Dec 31, 2019 $13.30M Feb 25, 2022
FY2020 Dec 31, 2018 $13.10M Feb 24, 2021
FY2019 Dec 31, 2017 $18.60M Feb 24, 2020
FY2018 Dec 31, 2016 $15.70M Feb 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.95B Feb 20, 2026
FY2025 Dec 31, 2024 $15.27B Feb 20, 2026
FY2024 Dec 31, 2023 $14.61B Feb 24, 2025
FY2023 Dec 31, 2022 $14.00B Feb 22, 2024
FY2022 Dec 31, 2021 $14.25B Feb 23, 2023
FY2021 Dec 31, 2020 $13.44B Feb 25, 2022
FY2020 Dec 31, 2019 $12.49B Feb 24, 2021
FY2019 Dec 31, 2018 $12.40B Feb 24, 2020
FY2018 Dec 31, 2017 $15.47B Feb 22, 2019
FY2017 Dec 31, 2016 $14.22B Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.37B Feb 20, 2026
FY2025 Dec 31, 2024 $12.43B Feb 20, 2026
FY2024 Dec 31, 2023 $12.15B Feb 24, 2025
FY2023 Dec 31, 2022 $11.66B Feb 22, 2024
FY2022 Dec 31, 2021 $11.11B Feb 23, 2023
FY2021 Dec 31, 2020 $10.24B Feb 25, 2022
FY2020 Dec 31, 2019 $9.57B Feb 24, 2021
FY2019 Dec 31, 2018 $9.45B Feb 24, 2020
FY2018 Dec 31, 2017 $12.47B Feb 22, 2019
FY2017 Dec 31, 2016 $11.36B Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.57B Feb 20, 2026
FY2025 Dec 31, 2024 $2.84B Feb 20, 2026
FY2025 Dec 31, 2023 $2.47B Feb 20, 2026
FY2024 Dec 31, 2022 $2.33B Feb 24, 2025
FY2023 Dec 31, 2021 $3.14B Feb 22, 2024
FY2022 Dec 31, 2020 $3.20B Feb 23, 2023
FY2021 Dec 31, 2019 $2.92B Feb 25, 2022
FY2020 Dec 31, 2018 $2.95B Feb 24, 2021
FY2019 Dec 31, 2017 $3.00B Feb 24, 2020
FY2018 Dec 31, 2016 $2.86B Feb 22, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $178.80M Feb 20, 2026
FY2025 Dec 31, 2024 $178.80M Feb 20, 2026
FY2024 Dec 31, 2023 $178.80M Feb 24, 2025
FY2023 Dec 31, 2022 $178.80M Feb 22, 2024
FY2022 Dec 31, 2021 $178.80M Feb 23, 2023
FY2021 Dec 31, 2020 $178.80M Feb 25, 2022
FY2020 Dec 31, 2019 $178.80M Feb 24, 2021
FY2019 Dec 31, 2018 $178.80M Feb 24, 2020
FY2018 Dec 31, 2017 $178.80M Feb 22, 2019
FY2017 Dec 31, 2016 $184.80M Feb 27, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.74B Feb 20, 2026
FY2025 Dec 31, 2024 $3.21B Feb 20, 2026
FY2024 Dec 31, 2023 $2.91B Feb 24, 2025
FY2023 Dec 31, 2022 $2.99B Feb 22, 2024
FY2022 Dec 31, 2021 $2.98B Feb 23, 2023
FY2021 Dec 31, 2020 $2.67B Feb 25, 2022
FY2020 Dec 31, 2019 $2.41B Feb 24, 2021
FY2019 Dec 31, 2018 $2.18B Feb 24, 2020
FY2018 Dec 31, 2017 $1.98B Feb 22, 2019
FY2017 Dec 31, 2016 $1.88B Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.12B Feb 20, 2026
FY2025 Dec 31, 2024 $435.50M Feb 20, 2026
FY2024 Dec 31, 2023 $316.10M Feb 24, 2025
FY2023 Dec 31, 2022 $305.00M Feb 22, 2024
FY2022 Dec 31, 2021 $230.90M Feb 23, 2023
FY2021 Dec 31, 2020 $120.60M Feb 25, 2022
FY2020 Dec 31, 2019 $215.70M Feb 24, 2021
FY2019 Dec 31, 2018 $1.02B Feb 24, 2020
FY2018 Dec 31, 2017 $297.90M Feb 22, 2019
FY2017 Dec 31, 2016 $282.60M Feb 27, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $843.30M Feb 20, 2026
FY2025 Dec 31, 2024 $722.30M Feb 20, 2026
FY2024 Dec 31, 2023 $783.20M Feb 24, 2025
FY2019 Dec 31, 2019 $653.40M Feb 24, 2020
FY2019 Dec 31, 2018 $777.90M Feb 24, 2020
FY2018 Dec 31, 2017 $786.90M Feb 22, 2019
FY2017 Dec 31, 2016 $786.40M Feb 27, 2018
FY2016 Dec 31, 2015 $803.10M Feb 22, 2017
FY2015 Dec 31, 2014 $903.50M Feb 25, 2016
FY2014 Dec 31, 2013 $903.90M Feb 24, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 18 Feb 20, 2026
FY2025 Dec 31, 2024 11 Feb 20, 2026
FY2025 Dec 31, 2023 0 Feb 20, 2026
FY2024 Dec 31, 2022 3 Feb 24, 2025
FY2023 Dec 31, 2021 11 Feb 22, 2024
FY2020 Dec 31, 2020 4 Feb 24, 2021
FY2020 Sep 30, 2020 3 Feb 24, 2021
FY2020 Jun 30, 2020 3 Feb 24, 2021
FY2020 Mar 31, 2020 (1) Feb 24, 2021
FY2020 Dec 31, 2019 2 Feb 24, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 18 Feb 20, 2026
FY2025 Dec 31, 2024 11 Feb 20, 2026
FY2025 Dec 31, 2023 0 Feb 20, 2026
FY2024 Dec 31, 2022 3 Feb 24, 2025
FY2023 Dec 31, 2021 11 Feb 22, 2024
FY2020 Dec 31, 2020 4 Feb 24, 2021
FY2020 Sep 30, 2020 3 Feb 24, 2021
FY2020 Jun 30, 2020 3 Feb 24, 2021
FY2020 Mar 31, 2020 (1) Feb 24, 2021
FY2020 Dec 31, 2019 2 Feb 24, 2021